Trump imposes 25% tariff on India over energy purchases from Russia

ET Graphics: As Trump slaps 25% tariff & penalty, a look into how Indian exports to US have risen over the years

11 months ago
President Trump has declared a 25% tariff on Indian goods and a penalty on Russian weapons and energy acquisitions. This action follows stalled trade negotiations due to disagreements over agricultural and dairy sector access. The new tariffs threaten India’s ambition to double bilateral trade with the US by 2030, impacting India’s largest export market.
Read More

Indian owners of three ships ask sanctions-hit Nayara Energy to release the vessels, sources say

11 months ago
Following EU sanctions, Indian vessel owners Seven Islands Shipping and Great Eastern Shipping Co (GESCO) have requested Nayara Energy to terminate contracts for three clean product tankers. Concerns over the sanctions have prompted this decision, impacting Nayara’s ability to sell refined fuel and leading to reduced refinery operations due to storage limitations.
Read More

Two days to go: No clarity over US tariffs, trade pact talks on

11 months ago
With the US tariff deadline looming, uncertainty surrounds India’s potential tariff rate despite ongoing trade negotiations. President Trump indicated tariffs of 15-20% for nations lacking separate trade deals, prompting concerns about a global trade contraction. While talks continue, India remains firm on duty concessions, and experts caution against viewing tariffs as a permanent US trade […]
Read More

India, UK trade pact does not mandate patent term extensions or data exclusivity

11 months ago
The India-UK free trade agreement safeguards the domestic generic drug industry. It avoids patent term extensions and data exclusivity. This prevents evergreening of patents. Indian patent law remains protected. The agreement, signed on July 24, will be effective in a year. India previously rejected similar demands from EFTA. The move ensures affordable medicines.
Read More

Safeguards for generics in UK FTA: Govt

11 months ago
The India-UK free trade agreement safeguards the interests of the Indian generic drugs industry. It does not allow patent extensions or data exclusivity. Indian patent laws remain protected. India will provide duty concessions on specific British agricultural products. Sensitive items like apples are excluded. Indian farmers will gain access to the UK market.
Read More

Create your account